首页> 外文OA文献 >Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
【2h】

Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice

机译:以CXCR4为主的内皮祖细胞的输血减少了db / db糖尿病小鼠的脑缺血损伤并促进了修复

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigated the role of stromal cell-derived factor-1α (SDF-1α)/CXC chemokine receptor 4 (CXCR4) axis in brain and endothelial progenitor cells (EPCs), and explored the efficacy of CXCR4 primed EPCs in treating ischemic stroke in diabetes. The db/db diabetic and db/+ mice were used in this study. Levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were measured. Brain SDF-1α and CXCR4 expression were quantified at basal and after middle cerebral artery occlusion (MCAO). In in vitro study, EPCs were transfected with adenovirus carrying null (Ad-null) or CXCR4 (Ad-CXCR4) followed with high glucose (HG) treatment for 4 days. For pathway block experiments, cells were pre-incubated with PI3K inhibitor or nitric oxide synthase (NOS) inhibitor for two hours. The CXCR4 expression, function and apoptosis of EPCs were determined. The p-Akt/Akt and p-eNOS/eNOS expression in EPCs were also measured. In in vivo study, EPCs transfected with Ad-null or Ad-CXCR4 were infused into mice via tail vein. On day 2 and 7, the cerebral blood flow, neurologic deficit score, infarct volume, cerebral microvascular density, angiogenesis and neurogenesis were determined. We found: 1) The levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were decreased in db/db mice; 2) The basal level of SDF-1α and MCAO-induced up-regulation of SDF-1α/CXCR4 axis were reduced in the brain of db/db mice; 3) Ad-CXCR4 transfection increased CXCR4 expression in EPCs and enhanced EPC colonic forming capacity; 4) Ad-CXCR4 transfection prevented EPCs from HG-induced dysfunction (migration and tube formation) and apoptosis via activation of PI3K/Akt/eNOS signal pathway; 4) Ad-CXCR4 transfection enhanced the efficacy of EPC infusion in attenuating infarct volume and promoting angiogenesis and neurogenesis. Our data suggest that Ad-CXCR4 primed EPCs have better therapeutic effects for ischemia stroke in diabetes than unmodified EPCs do.
机译:本研究调查了基质细胞衍生因子1α(SDF-1α)/ CXC趋化因子受体4(CXCR4)轴在脑和内皮祖细胞(EPC)中的作用,并探讨了CXCR4引发的EPC在治疗缺血性中风中的功效糖尿病。这项研究使用了db / db糖尿病小鼠和db / +小鼠。测量血浆SDF-1α和循环CD34 + CXCR4 +细胞的水平。在基础和大脑中动脉闭塞(MCAO)后定量脑SDF-1α和CXCR4的表达。在体外研究中,将EPC用携带空(Ad-null)或CXCR4(Ad-CXCR4)的腺病毒转染,然后进行高葡萄糖(HG)处理4天。对于途径阻断实验,将细胞与PI3K抑制剂或一氧化氮合酶(NOS)抑制剂预孵育2小时。测定了EPC的CXCR4表达,功能和凋亡。还测量了EPC中的p-Akt / Akt和p-eNOS / eNOS表达。在体内研究中,将Ad-null或Ad-CXCR4转染的EPC通过尾静脉注入小鼠。在第2天和第7天,测定脑血流量,神经功能缺损评分,梗塞体积,脑微血管密度,血管生成和神经发生。我们发现:1)db / db小鼠血浆SDF-1α和循环CD34 + CXCR4 +细胞水平降低; 2)降低了db / db小鼠大脑中SDF-1α的基础水平和MCAO诱导的SDF-1α/ CXCR4轴的上调; 3)Ad-CXCR4转染增加了EPC中CXCR4的表达并增强了EPC结肠形成能力; 4)Ad-CXCR4转染通过激活PI3K / Akt / eNOS信号通路阻止了EPCs引起的HG机能障碍(迁移和管形成)和细胞凋亡。 4)Ad-CXCR4转染增强了EPC输注的作用,可减轻梗死面积并促进血管生成和神经发生。我们的数据表明,与未经修饰的EPC相比,Ad-CXCR4引发的EPC对糖尿病缺血性卒中具有更好的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号